Fulgent Genetics gets EU approval for germline sequencing system
Source: SeekingAlpha
2025-07-17 10:16:20 ET
More on Fulgent Genetics
- Fulgent Genetics: A 'Sum Of The Parts' Story
- Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
- Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology
- Fulgent Genetics rises on earnings, revenue beat
- Seeking Alpha’s Quant Rating on Fulgent Genetics
Read the full article on Seeking Alpha
For further details see:
Fulgent Genetics gets EU approval for germline sequencing system
Fulgent Genetics Inc.
NASDAQ: FLGT
FLGT Trading
1.85% G/L:
$14.605 Last:
170,239 Volume:
$14.15 Open:
FLGT Latest News
February 12, 2026 07:30:00 am
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
FLGT Stock Data
$726,441,212
20,677,299
5.21%
56
N/A
Medical Diagnostics & Screening
Healthcare
US
El Monte
